Proteomic Profiling of Serum from Stage I Lung Squamous Cell Carcinoma Patients
Authors:
- Qi-Fei WuQWQi-Fei Wu
- Da-Lin HeDHDa-Lin He
- Jun-Ke FuJFJun-Ke Fu
- Xin JinXJXin Jin
Open Access
- 30 April 2013
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 14 (4) , 2273-2276
Abstract
Proteomic Profiling of Serum from Stage I Lung Squamous Cell Carcinoma Patients Lung cancer;squamous cell carcinoma;fibrinogen alpha chain;tumor biomarker; Objectives: This study employed proteomic profiling to identify specific tumor markers that might improve early diagnosis of lung squamous cell carcinoma. Methods: Serum samples were isolated from 30 patients with stage I lung squamous cell carcinoma and 30 age-and gender-matched healthy controls, and proteomic profiles were obtained by matrix-assisted laser desorption ionization time of flight mass spectrometry. Results: Three highly expressed potential tumor markers were identified in the sera of stage I lung squamous cell carcinoma patients, with molecular weights of 3261.69, 3192.07, and 2556.92 Da. One protein peak with molecular weight 3261.69 Da was chosen as the candidate biomarker and identified as a fibrinogen alpha chain through a search of the IPI, NCBI or SWISS-PROT protein databases. Conclusion: As a potential tumor biomarker, fibrinogen alpha chain may be applicable for the early diagnosis and prognosis of lung squamous cell carcinoma patients.Keywords
This publication has 12 references indexed in Scilit:
- The Utility of Fine-Needle Aspiration in the Diagnosis of Primary and Metastatic Tumors to the Lung: a Retrospective Examination of 1,032 CasesActa Cytologica, 2012
- Proteomics analysis in lung cancer: Challenges and opportunitiesRespirology, 2006
- Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clotBiochemical and Biophysical Research Communications, 2006
- Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancerLung Cancer, 2006
- Serum Peptide Profiling by Magnetic Particle-Assisted, Automated Sample Processing and MALDI-TOF Mass SpectrometryAnalytical Chemistry, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- CT Findings and Progression of Small Peripheral Lung Neoplasms Having a Replacement Growth PatternAmerican Journal of Roentgenology, 2003
- Carcinoembryonic Antigen, Squamous Cell Carcinoma Antigen, CYFRA 21-1, and Neuron-specific Enolase in Squamous Cell Lung Cancer PatientsClinical Chemistry, 2002
- Use of proteomic patterns in serum to identify ovarian cancerThe Lancet, 2002
- An Integrated Study of Fibrinogen during Blood CoagulationJournal of Biological Chemistry, 1999